Researchers
Discover all researchers in life sciences
Discover all researchers in life sciences
President at Pharmaceutical Chemistry
Ask questions about Abdul Samad's research, publications, and ongoing work
Utilized QSAR-based virtual screening to identify a novel hit as a SARS-CoV-2 29E 3CLpro inhibitor, supported by molecular docking and dynamics simulations.
Synthesized and evaluated newer oxadiazole derivatives, demonstrating significant antimicrobial activity and exploring their molecular properties.
Designed, synthesized, and biologically evaluated a series of 1,3,4-oxadiazole derivatives, contributing to the development of new therapeutic agents.
Explored the impact of particle shape on passive targeting in splenotropic drug delivery, identifying particle shape as a crucial design parameter.
Created polyethylene sebacate-doxorubicin nanoparticles for targeted drug delivery to the liver, enhancing therapeutic efficacy.
Designed, synthesized, and evaluated cinnamide derivatives using a molecular hybridization approach to develop novel antimycobacterial agents.
Developed a chitosan-based dry powder inhalation system for cisplatin delivery to treat lung cancer, improving drug delivery efficiency.
Identified potent aldose reductase inhibitors as antidiabetic agents using QSAR-based virtual screening, molecular docking, and MD simulation approaches.
Dr. Abdul Samad is a distinguished pharmaceutical chemist and academic leader, specializing in computational drug discovery, advanced drug delivery systems, and the synthesis of bioactive molecules. His research aims to identify novel therapeutic agents and improve drug delivery methods, contributing significantly to pharmaceutical innovation.
Researchers with overlapping expertise and complementary work
Finding similar researchers...